Engineering Antibody Evolution: Germline‐Targeting HIV Vaccines Reach a Turning Point

Rowena A. Bull, Deborah L. Burnett
Immunology and Cell Biology · Wiley · 2026-11-07 · DOI: 10.1111/imcb.70169
⬢ Cited by: 0 Crossref

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles